Lysergide

3 trials 1 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

5 Countries

Phase III

Phase II

Phase III: 1 Phase II: 2

Indications tested

Generalised anxiety disorder 1

Sponsors using this IMP

Definium Therapeutics US Inc. 1 Radboud universitair medisch centrum Stichting 1 Universiteit Maastricht 1

All trials

3 total

Microdosing for ADHD and emotion regulation Not authorised

2025-520906-36-00 Phase II 1 country Universiteit Maastricht
Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study Recruiting

2024-520305-39-00 Phase II 1 country Radboud universitair medisch centrum Stichting
A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Gen… Ended

2024-513572-17-00 Phase III 4 countries Definium Therapeutics US Inc.

Showing 1–3 of 3 trials

← All drugs A–Z